NGL Fine-Chem Limited (NGLFINE.BO)
INR 2040.15
(2.62%)
INR 2040.15
(2.62%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.38 Billion | 2.78 Billion | 3.17 Billion | 2.55 Billion | 1.48 Billion | 1.5 Billion |
| Cost of Revenue | 2.15 Billion | 1.4 Billion | 1.46 Billion | 1.02 Billion | 643.66 Million | 626.36 Million |
| Gross Profit | 1.23 Billion | 1.37 Billion | 1.7 Billion | 1.52 Billion | 845.87 Million | 881.38 Million |
| Operating Expenses | 816.16 Million | 1.14 Billion | 1.13 Billion | 763.31 Million | 706.97 Million | 586.38 Million |
| Selling, General and Administrative Expenses | 816.16 Million | 208.86 Million | 148.7 Million | 103.82 Million | 78.6 Million | 69.6 Million |
| Research and Development Expenses | - | 24.31 Million | 17.37 Million | 18.69 Million | 21.97 Million | 14.2 Million |
| Other Expenses | - | 55.3 Million | 106.82 Million | 12.52 Million | 846.15 Thousand | 7.79 Million |
| Cost and Expenses | 2.97 Billion | 2.55 Billion | 2.6 Billion | 1.78 Billion | 1.35 Billion | 1.21 Billion |
| Operating Income | 416.27 Million | 236.65 Million | 578.26 Million | 763.25 Million | 111.58 Million | 268.39 Million |
| Interest Expense | 18.09 Million | 11.97 Million | 15.61 Million | 18.4 Million | 22.55 Million | 22.87 Million |
| Income Tax Expense | 131 Million | 68.65 Million | 166.99 Million | 208.7 Million | 37.36 Million | 74.39 Million |
| Earnings before Tax | 544.17 Million | 273.62 Million | 665.96 Million | 775.89 Million | 120.72 Million | 275.66 Million |
| Net Income | 413.16 Million | 204.96 Million | 498.97 Million | 567.19 Million | 83.35 Million | 201.26 Million |
| Earnings Per Share Basic | 66.88 | 33.18 | 80.77 | 91.81 | 13.49 | 32.58 |
| Earnings Per Share Diluted | 66.88 | 33.18 | 80.77 | 91.81 | 13.49 | 32.58 |
| Weighted Average Shares Outstanding | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million |
| Gross Margin | 0.36 | 0.50 | 0.54 | 0.60 | 0.57 | 0.58 |
| EBIT Margin | 0.20 | 0.14 | 0.25 | 0.34 | 0.17 | 0.26 |
| Profit Margin | 0.12 | 0.07 | 0.16 | 0.22 | 0.06 | 0.13 |
| EBITDA | 678.68 Million | 404.87 Million | 788.78 Million | 881.27 Million | 228.09 Million | 361.53 Million |
| Earnings Before Tax Margin | 0.12 | 0.09 | 0.18 | 0.30 | 0.07 | 0.18 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 907.53 Million | 997.6 Million | 3.38 Billion | 879.51 Million | 801.78 Million | 710.42 Million |
| Cost of Revenue | 620.93 Million | 623.2 Million | 2.15 Billion | 412.54 Million | 362.03 Million | 339.26 Million |
| Gross Profit | 286.59 Million | 374.4 Million | 1.23 Billion | 466.96 Million | 439.74 Million | 371.15 Million |
| Operating Expenses | 223.14 Million | 245.38 Million | 816.16 Million | 357.72 Million | 328.95 Million | 301.1 Million |
| Selling, General and Administrative Expenses | 223.14 Million | 245.38 Million | - | 213.12 Million | 191.08 Million | 166.43 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 58.84 Million | 39.62 Million | 141.28 Million | 36.79 Million | 32.18 Million | 33.21 Million |
| Cost and Expenses | 844.07 Million | 868.59 Million | 2.97 Billion | 770.27 Million | 690.98 Million | 640.36 Million |
| Operating Income | 63.45 Million | 129.01 Million | 416.27 Million | 146.04 Million | 110.79 Million | 70.05 Million |
| Interest Expense | 4.43 Million | 4.58 Million | 13.38 Million | 2.75 Million | 3.62 Million | 2.42 Million |
| Income Tax Expense | 25.67 Million | 37.69 Million | 131 Million | 42.95 Million | 34.58 Million | 15.77 Million |
| Earnings before Tax | 117.87 Million | 160.94 Million | 544.17 Million | 143.29 Million | 139.36 Million | 100.84 Million |
| Net Income | 92.19 Million | 122.98 Million | 413.16 Million | 100.33 Million | 104.78 Million | 85.06 Million |
| Earnings Per Share Basic | 14.92 | 19.95 | - | 16.24 | 16.96 | 13.77 |
| Earnings Per Share Diluted | 14.92 | 19.95 | - | 16.24 | 16.96 | 13.77 |
| Weighted Average Shares Outstanding | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million | 6.17 Million |
| Gross Margin | 0.32 | 0.38 | 0.36 | 0.53 | 0.55 | 0.52 |
| EBIT Margin | 0.10 | 0.16 | - | 0.20 | 0.21 | 0.19 |
| Profit Margin | 0.10 | 0.12 | 0.12 | 0.11 | 0.13 | 0.12 |
| EBITDA | 93.5 Million | 158.22 Million | - | 175.47 Million | 171.88 Million | 131.85 Million |
| Earnings Before Tax Margin | 0.07 | 0.13 | 0.12 | 0.17 | 0.14 | 0.10 |
THEMISMED
8929
GZTGF
MTA
BEML
4015